Congenital anomalies in children of mothers taking antiepileptic drugs with and without periconceptional high dose folic acid use: A population-based cohort study

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Ban, Lu ^a   Fleming, Kate M ^a   Doyle, Pat ^b   Smeeth, Liam ^b   Hubbard, Richard B ^a   Fiaschi, Linda ^a   Tata, Laila J ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; FOLIC ACID; LAMOTRIGINE; VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; CHILD; COHORT ANALYSIS; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; CONTROLLED STUDY; DRUG MEGADOSE; EPILEPSY; FEMALE; FIRST TRIMESTER PREGNANCY; GENITAL MALFORMATION; HUMAN; LIMB MALFORMATION; MAJOR CLINICAL STUDY; MATERNAL OBESITY; MATERNAL SMOKING; MINERAL SUPPLEMENTATION; PRENATAL DRUG EXPOSURE; PRESCRIPTION; RISK; SECOND TRIMESTER PREGNANCY; SOCIAL STATUS; ABNORMALITIES, DRUG-INDUCED; COMORBIDITY; CONGENITAL ABNORMALITIES; DOSE RESPONSE; DRUG EFFECTS; DRUG UTILIZATION; ODDS RATIO; ORGANOGENESIS; OVERWEIGHT; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL CARE; PREPREGNANCY CARE; SAMPLE SIZE; SMOKING; STATISTICS AND NUMERICAL DATA; UNITED KINGDOM; YOUNG ADULT;

ABNORMALITIES, DRUG-INDUCED; ADOLESCENT; ADULT; ANTICONVULSANTS; COHORT STUDIES; COMORBIDITY; CONGENITAL ABNORMALITIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG PRESCRIPTIONS; DRUG UTILIZATION; EPILEPSY; FEMALE; FOLIC ACID; HUMANS; ODDS RATIO; ORGANOGENESIS; OVERWEIGHT; PRECONCEPTION CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; PRENATAL CARE; RISK; SAMPLE SIZE; SMOKING; UNITED KINGDOM; YOUNG ADULT;

EID: 84940182072     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0131130     Document Type: Article

References (48)

1. Wallace H, Shorvon S, Tallis R. Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2 052 922 and age-specific fertility rates of women with epilepsy. The Lancet. 1998; 352: 1970-1973. doi: 10.1016/S0140-6736(98)04512-7
2. Chen Y, Chiou H, Lin H, Lin H. Affect of seizures during gestation on pregnancy outcomes in women with epilepsy. Arch Neurol. 2009; 66: 979-984. doi: 10.1001/archneurol.2009.142 PMID: 19667219
3. Meador K, Reynolds MW, Crean S, Fahrbach K, Probst C. Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts. Epilepsy Research. 2008; 81: 1-13. doi: 10.1016/j.eplepsyres.2008.04.022 PMID: 18565732
4. Diav-Citrin O, Shechtman S, Bar-Oz B, Cantrell D, Arnon J, Ornoy A. Pregnancy outcome after in utero exposure to valproate: evidence of dose relationship in teratogenic effect. CNS Drugs. 2008; 22: 325-334. PMID: 18336060
5. Jentink J, Loane MA, Dolk H, Barisic I, Garne E, Morris JK, et al. Valproic acid monotherapy in pregnancy and major congenital malformations. New England Journal of Medicine. 2010; 362: 2185-2193. doi: 10.1056/NEJMoa0907328 PMID: 20558369
6. Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Sabers A, et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. The Lancet Neurology. 2011; 10: 609-617. doi: 10.1016/S1474-4422(11)70107-7 PMID: 21652013
7. Hernández-Díaz S, Smith CR, Shen A, Mittendorf R, Hauser WA, Yerby M, et al. Comparative safety of antiepileptic drugs during pregnancy. Neurology. 2012; 78: 1692-1699. doi: 10.1212/WNL.0b013e3182574f39 PMID: 22551726
8. Mawhinney E, Campbell J, Craig J, Russell A, Smithson W, Parsons L, et al. Valproate and the risk for congenital malformations: Is formulation and dosage regime important? Seizure. 2012; 21: 215-218. doi: 10.1016/j.seizure.2012.01.005 PMID: 22364656
9. Vajda FJO'Brien TJ, Graham JE, Lander CM, Eadie MJ. Dose dependence of fetal malformations associated with valproate. Neurology. 2013; 81: 999-1003. doi: 10.1212/WNL.0b013e3182a43e81 PMID: 23911758
10. NICE. CG137 Epilepsy: full guideline. In: NICE [Internet]. Available: http://www.nice.org.uk/. Accessed 17 May 2013.
11. Harden CL, Meador KJ, Pennell PB, Hauser WA, Gronseth GS, French JA, et al. Practice Parameter update: Management issues for women with epilepsy - Focus on pregnancy (an evidence-based review): Teratogenesis and perinatal outcomes Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology. 2009; 73: 133-141. doi: 10.1212/WNL.0b013e3181a6b312 PMID: 19398681
12. Jentink J, Dolk H, Loane MA, Morris JK, Wellesley D, Garne E, et al. Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study. BMJ. 2010; 341: c6581-c6581. doi: 10.1136/bmj.c6581 PMID: 21127116
13. Hernández-Díaz S, Werler MM, Walker AM, Mitchell AA. Neural tube defects in relation to use of folic acid antagonists during pregnancy. Am J Epidemiol. 2001; 153: 961-968. doi: 10.1093/aje/153.10.961 PMID: 11384952
14. Mawhinney E, Craig J, Morrow J, Russell A, Smithson WH, Parsons L, et al. Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers. Neurology. 2013; 80: 400-405. doi: 10.1212/WNL.0b013e31827f0874 PMID: 23303847
15. Mølgaard-Nielsen D HA. Newer-generation antiepileptic drugs and the risk of major birth defects. JAMA. 2011; 305: 1996-2002. doi: 10.1001/jama.2011.624 PMID: 21586715
16. Man S-L, Petersen I, Thompson M, Nazareth I. Antiepileptic drugs during pregnancy in primary care: a UK population based study. PLoS ONE. 2012; 7: e52339. doi: 10.1371/journal.pone.0052339 PMID: 23272239
17. NICE. CG62 Antenatal care: NICE guideline [Internet]. [cited 14 Jun 2011]. Available: http://guidance.nice.org.uk/CG62/NICEGuidance/pdf/English
18. Morrow JI, Hunt SJ, Russell AJ, Smithson WH, Parsons L, Robertson I, et al. Folic acid use and major congenital malformations in offspring of women with epilepsy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry. 2009; 80: 506-511. doi: 10.1136/jnnp.2008.156109 PMID: 18977812
19. Hernández-Díaz S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. New England Journal of Medicine. 2000; 343: 1608-1614. doi: 10.1056/NEJM200011303432204 PMID: 11096168
20. Vajda FJE, Hitchcock A, Graham J, Solinas C, O'Brien TJ, Lander CM, et al. Foetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry. European Journal of Neurology. 2006; 13: 645-654. doi: 10.1111/j.1468-1331.2006.01359.x PMID: 16796590
21. Jentink J, Bakker MK, Nijenhuis CM, Wilffert B, de Jong-van den Berg LTW. Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid? Pharmacoepidemiology and Drug Safety. 2010; 19: 803-807. doi: 10.1002/pds.1975 PMID: 20680999
22. Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidem Drug Safe. 2007; 16: 393-401. doi: 10.1002/pds.1335
23. Ban L, West J, Abdul Sultan A, Dhalwani N, Ludvigsson J, Tata L. Limited risks of major congenital anomalies in children of mothers with coeliac disease: a population-based cohort study. BJOG: Int J Obstet Gy. 2014; n/a - n/a. doi: 10.1111/1471-0528.13102
24. Sokal R, Fleming KM, Tata LJ. Potential of general practice data for congenital anomaly research: comparison with registry data in the United Kingdom. Birth Defects Research Part A: Clinical and Molecular Teratology. 2013; 97: 546-553. doi: 10.1002/bdra.23150
25. EUROCAT. Coding of EUROCAT subgroups of congenital anomalies [Internet]. 2012. Available: http://www.eurocat-network.eu/content/EUROCAT-Guide-1.3-Chapter-3.3-Jan13.pdf.
26. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet. 1991; 338: 131-137. PMID: 1677062
27. Czeizel AE, Dudás I. Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin Supplementation. New England Journal of Medicine. 1992; 327: 1832-1835. doi: 10.1056/NEJM199212243272602 PMID: 1307234
28. Joint Formulary Committee. British National Formulary (BNF) 63. 63rd Revised edition. Pharmaceutical Press; 2012.
29. Ali M. Investigating the use of medicines in management of children and young people with epilepsy using data from primary care in the UK [Internet]. PhD, University of Nottingham. 2012. Available: http://etheses.nottingham.ac.uk/2898/
30. World Health Organization. BMI classification [Internet]. [cited 9 Jan 2014]. Available: http://apps.who.int/bmi/index.jsp?introPage=intro-3.html.
31. Prajapati B, Dunne M, Armstrong R. Sample size estimation and statistical power analyses. Optometry Today. July 16. Available: http://www.optometry.co.uk/clinical/details?aid=634. Accessed 10 May 2012.
32. Morrow J, Russell A, Guthrie E, Parsons L, Robertson I, Waddell R, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK epilepsy and pregnancy register. J Neurol Neurosurg Psychiatry. 2006; 77: 193-198. doi: 10.1136/jnnp.2005.074203 PMID: 16157661
33. Leppik IE. How to get patients with epilepsy to take their medication. The problem of noncompliance. Postgrad Med. 1990; 88: 253-256. PMID: 2367256
34. Say L, Donner A, Gülmezoglu AM, Taljaard M, Piaggio G. The prevalence of stillbirths: a systematic review. Reproductive Health. 2006; 3: 1. doi: 10.1186/1742-4755-3-1 PMID: 16401351
35. The Stillbirth Collaborative Research Network. Causes of death among stillbirths. JAMA. 2011; 306: 2459-2468. doi: 10.1001/jama.2011.1823 PMID: 22166605
36. Confidential Enquiry into Maternal and Child Health (CEMACH). Perinatal Mortality 2007: United Kingdom [Internet]. CEMACH: London 2009; Available: http://www.hqip.org.uk/assets/NCAPOP-Library/CMACE-Reports/37.-June-2009-Perinatal-Mortality-2007.pdf.
37. European Surveillance of Congenital Anomalies. EUROCAT prevalence tables [Internet]. [cited 21 Apr 2015]. Available: http://www.eurocat-network.eu/accessprevalencedata/prevalencetables.
38. BINOCAR. Congenital Anomaly Statistics 2010 England and Wales [Internet]. 2012. Available: http://www.binocar.org/content/Annual%20report%202010%20FINAL%2031-07-12%20v2.pdf.
39. Department of Health. Abortion statistics, England and Wales, 2010 [Internet]. 24 May 2011. Available: http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsStatistics/DH-126769. Accessed 21 June 2012.
40. Grosse SD, Collins JS. Folic acid supplementation and neural tube defect recurrence prevention. Birth Defects Research Part A: Clinical and Molecular Teratology. 2007; 79: 737-742. doi: 10.1002/bdra.20394 PMID: 17990333
41. Thomas SV, Ajaykumar B, Sindhu K, Francis E, Namboodiri N, Sivasankaran S, et al. Cardiac malformations are increased in infants of mothers with epilepsy. Pediatr Cardiol. 2008; 29: 604-608. doi: 10.1007/s00246-007-9161-4 PMID: 18188637
42. Kaaja E, Kaaja R, Hiilesmaa V. Major malformations in offspring of women with epilepsy. Neurology. 2003; 60: 575-579. PMID: 12601095
43. Holmes LB, Harvey EA, Coull BA, Huntington KB, Khoshbin S, Hayes AM, et al. The teratogenicity of anticonvulsant drugs. N Engl J Med. 2001; 344: 1132-8. PMID: 11297704
44. Queisser-Luft A, Eggers I, Stolz G, Kieninger-Baum D, Schlaefer K. Serial examination of 20,248 newborn fetuses and infants: correlations between drug exposure and major malformations. Am J Med Genet. 1996; 63: 268-76. PMID: 8723120
45. Kulaga S, Sheehy O, Zargarzadeh AH, Moussally K, Bérard A. Antiepileptic drug use during pregnancy: Perinatal outcomes. Seizure. 2011; 20: 667-672. doi: 10.1016/j.seizure.2011.06.012 PMID: 21763158
46. Cassina M, Dilaghi A, Di Gianantonio E, Cesari E, De Santis M, Mannaioni G, et al. Pregnancy outcome in women exposed to antiepileptic drugs: Teratogenic role of maternal epilepsy and its pharmacologic treatment. Reproductive Toxicology. 2013; 39: 50-57. doi: 10.1016/j.reprotox.2013.04.002 PMID: 23591043
47. Gelder MMHJ, van Rooij IALM, van Miller RK, Zielhuis GA, Berg LTW de J den, Roeleveld N. Teratogenic mechanisms of medical drugs. Hum Reprod Update. 2010; 16: 378-394. doi: 10.1093/humupd/dmp052 PMID: 20061329
48. Linnebank M, Moskau S, Semmler A, Widman G, Stoffel-Wagner B, Weller M, et al. Antiepileptic drugs interact with folate and vitamin B12 serum levels. Annals of Neurology. 2011; 69: 352-359. doi: 10.1002/ana.22229 PMID: 21246600